BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33195154)

  • 1. Multiplex Genome Engineering Methods for Yeast Cell Factory Development.
    Malcı K; Walls LE; Rios-Solis L
    Front Bioeng Biotechnol; 2020; 8():589468. PubMed ID: 33195154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the application of multiplex genome editing in Saccharomyces cerevisiae.
    Zhang ZX; Wang LR; Xu YS; Jiang WT; Shi TQ; Sun XM; Huang H
    Appl Microbiol Biotechnol; 2021 May; 105(10):3873-3882. PubMed ID: 33907890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-copy genome integration of 2,3-butanediol biosynthesis pathway in Saccharomyces cerevisiae via in vivo DNA assembly and replicative CRISPR-Cas9 mediated delta integration.
    Huang S; Geng A
    J Biotechnol; 2020 Feb; 310():13-20. PubMed ID: 32006629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
    Patra P; Das M; Kundu P; Ghosh A
    Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly efficient single-step, markerless strategy for multi-copy chromosomal integration of large biochemical pathways in Saccharomyces cerevisiae.
    Shi S; Liang Y; Zhang MM; Ang EL; Zhao H
    Metab Eng; 2016 Jan; 33():19-27. PubMed ID: 26546089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient CRISPR-Cas9 mediated multiplex genome editing in yeasts.
    Wang L; Deng A; Zhang Y; Liu S; Liang Y; Bai H; Cui D; Qiu Q; Shang X; Yang Z; He X; Wen T
    Biotechnol Biofuels; 2018; 11():277. PubMed ID: 30337956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing systems across yeast species.
    Yang Z; Blenner M
    Curr Opin Biotechnol; 2020 Dec; 66():255-266. PubMed ID: 33011454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex Genome Editing in Yeast by CRISPR/Cas9 - A Potent and Agile Tool to Reconstruct Complex Metabolic Pathways.
    Utomo JC; Hodgins CL; Ro DK
    Front Plant Sci; 2021; 12():719148. PubMed ID: 34421973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
    Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in gene editing technologies for Saccharomyces cerevisiae].
    Li H; Liang X; Zhou J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):950-965. PubMed ID: 33783160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Systems for the Development of
    Meng J; Qiu Y; Shi S
    Front Bioeng Biotechnol; 2020; 8():594347. PubMed ID: 33330425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex Genome Engineering for Optimizing Bioproduction in Saccharomyces cerevisiae.
    Auxillos JY; Garcia-Ruiz E; Jones S; Li T; Jiang S; Dai J; Cai Y
    Biochemistry; 2019 Mar; 58(11):1492-1500. PubMed ID: 30817136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and Opportunities of CRISPR/Cas Technology in Bioengineering Non-conventional Yeasts.
    Shan L; Dai Z; Wang Q
    Front Bioeng Biotechnol; 2021; 9():765396. PubMed ID: 34708030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic genome engineering forging new frontiers for wine yeast.
    Pretorius IS
    Crit Rev Biotechnol; 2017 Feb; 37(1):112-136. PubMed ID: 27535766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACtivE: Assembly and CRISPR-Targeted
    Malcı K; Jonguitud-Borrego N; van der Straten Waillet H; Puodžiu Naitė U; Johnston EJ; Rosser SJ; Rios-Solis L
    ACS Synth Biol; 2022 Nov; 11(11):3629-3643. PubMed ID: 36252276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
    Giersch RM; Finnigan GC
    Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae.
    Jakočiūnas T; Bonde I; Herrgård M; Harrison SJ; Kristensen M; Pedersen LE; Jensen MK; Keasling JD
    Metab Eng; 2015 Mar; 28():213-222. PubMed ID: 25638686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing GDi-CRISPR System for Multi-copy Integration in Saccharomyces cerevisiae.
    Zhang ZX; Wang YZ; Xu YS; Sun XM; Huang H
    Appl Biochem Biotechnol; 2021 Jul; 193(7):2379-2388. PubMed ID: 33660219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Kluyveromyces marxianus as a Robust Synthetic Biology Platform Host.
    Cernak P; Estrela R; Poddar S; Skerker JM; Cheng YF; Carlson AK; Chen B; Glynn VM; Furlan M; Ryan OW; Donnelly MK; Arkin AP; Taylor JW; Cate JHD
    mBio; 2018 Sep; 9(5):. PubMed ID: 30254120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.